title: Codevelopment of new antiretrovirals in very treatment-experienced HIV-infected individuals.
authors.forename: Mike
authors.initials: M
authors.lastname: Youle
authors.forename: Cal
authors.initials: C
authors.lastname: Cohen
authors.forename: Christine
authors.initials: C
authors.lastname: Katlama
authors.forename: Dan
authors.initials: D
authors.lastname: Kuritzkes
authors.forename: Sharon
authors.initials: S
authors.lastname: Walmsley
mesh_terms: D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational / Q000008:administration & dosage*; D000077560:Enfuvirtide; D015700:HIV Envelope Protein gp41 / Q000627:therapeutic use; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010446:Peptide Fragments / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011753:Pyrones / Q000627:therapeutic use; D013449:Sulfonamides
chemical_list: D044966:Anti-Retroviral Agents; D015507:Drugs, Investigational; D015700:HIV Envelope Protein gp41; D023581:HIV Fusion Inhibitors; D010446:Peptide Fragments; D011725:Pyridines; D011753:Pyrones; D013449:Sulfonamides; D000077560:Enfuvirtide; C107201:tipranavir